Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 2
Abstract
[b]Background and aim.[/b] The commonly accepted treatment for hepatitis C virus (HCV) infection, pegylated interferon alpha (PEG INF-alpha) and ribavirin, leads to 50-60% of sustained virological response (SVR). On the other hand, pentoxifylline (PTX) possesses antiviral and hepatoprotector properties. [b]Aim[/b]. To investigate whether the addition of PTX to conventional hepatitis C treatment increases SVR. [b]Material and methods. [/b]Seventy two patients of both genders were studied in a randomized fashion; the diagnosis of chronic HCV infection was made according to clinical and laboratory criteria and histopathologically classified according to METAVIR scoring system criteria. HCV viral load was tested by PCR, baseline, and after 6 months of treatment, as well as anti-HCV, anti-hepatitis B virus , and anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay. During 48 weeks, control group patients were treated with PEG INFalpha- 2a plus ribavirin. PTX was administered to Experimental Group patients prior to the treatment. [b]Results[/b]. Demographic data were similar in both groups. Experimental- and control-group subjects were at F2 and F3 states according to the METAVIR classification. The most common HCV genotypes were 1a and 1b (39% in the control group in each case, and 42% in the experimental group in each case). At the end of the study, hepatic enzymes and viral load decreased in both groups to similar values. SVR in the experimental group increased significantly (p < 0.05) when compared with standard therapy alone. [b]Conclusion[/b]. Addition of PTX to conventional chronic hepatitis C treatment may increase the percentage of patients with SVR.
Authors and Affiliations
Miguel Jiménez-Luévano, José Lerma-Díaz, Georgina Hernández-Flores, Alejandro Bravo-Cuellar
Keywords
Related Articles
- EP ID EP78258
- DOI -
- Views 133
- Downloads 0
Silybin/Silymarin treatment in chronic hepatitis C
Chilaiditi syndrome. An uncommon cause of crampy, upper abdominal pain
Band ligation vs. N-Butyl-2-cyanoacrylate injection in acute gastric variceal bleeding: a prospective follow-up study
Background. Treatment of gastric varices (GV) implies a number of several difficulties and sometimes entails complications. The best endoscopic success rate was attributed until now to the use of tissue adhesives(N-Butyl...
Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key
The use of calcineurin inhibitors (CNI) after liver transplantation is associated with post-transplant nephrotoxicity. Conversion to mycophenolate mofetil (MMF) monotherapy improves renal function, but is related to gra...
Portopulmonary hypertension: state of the art
Portopulmonary hypertension is an uncommon but treatable pulmonary vascular consequence of portal hypertension, which can lead to significant morbidity and mortality. Portopulmonary hypertension results from excessive pu...